Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab and Vinorelbine in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)
- Status
- COMPLETED
- Phase
- PHASE1